Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)

Journal of Cystic Fibrosis

Volumn 7, Issue 6, 2008, Pages 515-519

  van den Berg, Johanna M W ^a   Morton, Alison M ^b   Kok, Simon W ^a   Pijl, Hanno ^c   Conway, Steven P ^b   Heijerman, Harry G M ^a  

^a HAGA HOSPITAL   (Netherlands)

^b SEACROFT HOSPITAL   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cystic fibrosis; Cystic fibrosis related diabetes (CFRD); Microvascular complications; Type 1 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; MICROVESSELS; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 55349141380     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2008.05.008     Document Type: Article

References (32)

1. Slieker M.G., Uiterwaal C.S., Sinaasappel M., Heijerman H.G., van der L.J., and van der Ent C.K. Birth prevalence and survival in cystic fibrosis: a national cohort study in the Netherlands. Chest 128 4 (2005) 2309-2315
2. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med 173 5 (2006) 475-482
3. http://www.cff.org. Cystic fibrosis foundation patient registry. Annual database report. 2002. Bethesda, Cystic fibrosis foundation.
4. Moran A., Hardin D., Rodman D., Allen H.F., Beall R.J., Borowitz D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 45 1 (1999) 61-73
5. Mackie A.D., Thornton S.J., and Edenborough F.P. Cystic fibrosis-related diabetes. Diabet Med 20 6 (2003) 425-436
6. Dolan Jr. T.F. Microangiopathy in a young adult with cystic fibrosis and diabetes mellitus. N Engl J Med 314 15 (1986) 991-992
7. Allen J.L. Progressive nephropathy in a patient with cystic fibrosis and diabetes. N Engl J Med 315 12 (1986) 764
8. Rodman H.M., Waltman S.R., Krupin T., Lee A.T., Frank K.E., and Matthews L.W. Quantitative vitreous fluorophotometry in insulin-treated cystic fibrosis patients. Diabetes 32 6 (1983) 505-508
9. Sullivan M.M., and Denning C.R. Diabetic microangiopathy in patients with cystic fibrosis. Pediatrics 84 4 (1989) 642-647
10. Yung B., Landers A., Mathalone B., Gyi K.M., and Hodson M.E. Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes. Respir Med 92 6 (1998) 871-872
11. Lanng S., Thorsteinsson B., Lund-Andersen C., Nerup J., Schiotz P.O., and Koch C. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 83 1 (1994) 72-77
12. Scott A.I., Clarke B.E., Healy H., Emden D., and Bell S.C. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. JOP 1 4 (2000) 208-210
13. Andersen H.U., Lanng S., Pressler T., Laugesen C.S., and Mathiesen E.R. Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications. Diabetes Care 29 12 (2006) 2660-2663
14. Schwarzenberg S.J., Thomas W., Olsen T.W., Grover T., Walk D., Milla C., et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 30 5 (2007) 1056-1061
15. Kerem E., Conway S., Elborn S., and Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 4 1 (2005) 7-26
16. Bakker A.J., and de Grauw W.J. [Methods of collecting urine for the determination of microalbuminuria: time for consensus]. Ned Tijdschr Geneeskd 148 41 (2004) 2012-2015
17. Van Dam P.S., Valk G.D., and Bakker K. [Diabetic peripheral neuropathy: international guidelines for prevention, diagnosis, and treatment]. Ned Tijdschr Geneeskd 144 9 (2000) 418-421
18. Boulton A.J. Guidelines for diagnosis and outpatient management of diabetic peripheral neuropathy.European Association for the Study of Diabetes, Neurodiab. Diabetes Metab 24 Suppl 3 (1998) 55-65
19. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44 8 (1995) 968-983
20. Brennan A.L., Gyi K.M., Wood D.M., Hodson M.E., Geddes D.M., and Baker E.H. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros 5 1 (2006) 27-31
21. Ekstrand A.V., Groop P.H., and Gronhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant 13 12 (1998) 3079-3083
22. Navarro J.F., Mora C., Maca M., and Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 42 1 (2003) 53-61
23. Saraheimo M., Teppo A.M., Forsblom C., Fagerudd J., and Groop P.H. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients. Diabetologia 46 10 (2003) 1402-1407
24. Hardin D.S., Leblanc A., Marshall G., and Seilheimer D.K. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 281 5 (2001) E1022-E1028
25. Al Aloul M., Miller H., Alapati S., Stockton P.A., Ledson M.J., and Walshaw M.J. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 39 1 (2005) 15-20
26. Godson C., Ryan M.P., O'Halloran D., Bourke S., Brady H.R., and FitzGerald M.X. Investigation of aminoglycoside nephrotoxicity in cystic fibrosis patients. Scand J Gastroenterol Suppl 143 (1988) 70-73
27. Steinkamp G., Lutge M., Wurster U., Schulz-Baldes J.G., Grone H.J., and Ehrich J.H. Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy. Eur J Pediatr 145 6 (1986) 526-531
28. Stephens S.E., and Rigden S.P. Cystic fibrosis and renal disease. Paediatr Respir Rev 3 2 (2002) 135-138
29. Stirati G., Antonelli M., Fofi C., Fierimonte S., and Pecci G. IgA nephropathy in cystic fibrosis. J Nephrol 12 1 (1999) 30-31
30. Gaffney K., Gibbons D., Keogh B., and Fitzgerald M.X. Amyloidosis complicating cystic fibrosis. Thorax 48 9 (1993) 949-950
31. Westall G.P., Binder J., Kotsimbos T., Topliss D., Thomson N., Dowling J., et al. Nodular glomerulosclerosis in cystic fibrosis mimics diabetic nephropathy. Nephron Clin Pract 96 3 (2004) c70-c75
32. Dobson L., Stride A., Bingham C., Elworthy S., Sheldon C.D., and Hattersley A.T. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Pediatr Pulmonol 39 2 (2005) 103-107